Atropine
Aussie myopia study reveals who benefits the most from low-dose atropine
Ancestry may be a factor in the effectiveness of low-dose atropine eye drops for myopia control, according to an Australian-first...
Read more
Low-dose atropine EIKANCE secures first myopia TGA approval
The Therapeutic Goods Administration (TGA) has approved EIKANCE 0.01%, Australia’s first low-dose atropine eye drop for myopia progression in children...
Read more